Intravenous dipyridamole: Body weight considerations and dosage requirements
Authors:
- 1 March 1989
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 117 (3) , 702-704
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Safety and diagnostic accuracy of dipyridamole-thallium imaging in the elderlyJACC, 1988
- Prolonged Myocardial Ischemia after Intravenous Dipyridamole Thallium ImagingChest, 1987
- Safety of intravenous dipyridamole for stress testing with thallium imagingThe American Journal of Cardiology, 1987
- High dose dipyridamole echocardiography test in effort angina pectorisJACC, 1986
- Alterations in drug distribution and clearance due to obesity.The Journal of Pharmacology and Experimental Therapeutics, 1981
- Pharmacokinetics of DipyridamoleActa Pharmacologica et Toxicologica, 1979
- A Controlled Investigation of the Pharmacokinetics of Gentamicin and Tobramycin in Obese SubjectsThe Journal of Infectious Diseases, 1978
- Theophylline disposition in obesityClinical Pharmacology & Therapeutics, 1978
- Effect of nitroglycerin and dipyridamole on regional left ventricular blood flow during coronary artery occlusion.Journal of Clinical Investigation, 1976
- Digoxin Metabolism in ObesityCirculation, 1971